Neuralink celebrates the anniversary of its first human implant as it moves toward the beginning of its brain chip trials expanding to Miami.

Elon Musk’s Neuralink has selected Miami as a clinical trial site for its brain-computer interface. Musk’s Neuralink makes devices that link the human brain to computers, focusing on giving people with quadriplegia or paralysis the ability to control computers and devices with their thoughts.

Musk’s startup company Neuralink has tapped the University of Miami’s Miller School of Medicine to be the second site in the country to test whether its brain chip can give people who are paralyzed the ability to use mind to wirelessly control computers, smartphones and other electronic devices.

“It’s like using the Force” on a computer cursor, according to Noland Arbaugh, referencing the Star Wars energy field. Arbaugh is a quadriplegic and the first person to get the Neuralink brain chip implant in January 2024 at the Barrow Neurological Institute in Phoenix.

Neuralink selected the University of Miami Miller School of Medicine as its second site to conduct clinical trials on the innovative idea. Levi is a neurosurgeon and clinical director for the school.

Neuralink advances brain-computer interfaces, implanting a third patient, improving battery life, receiving FDA/Canada approvals, while competitors like Synchron

The University of Miami on Monday announced that it will be the second U.S.-based site for Elon Musk’s Neuralink’s PRIME Study.